Tranzyme Pharma Receives IND Clearance For Its Oral Ghrelin Agonist, TZP-102, For The

		Plastic Surgery user forums > Plastic Surgery News
Tranzyme Pharma Receives IND Clearance For Its Oral Ghrelin Agonist, TZP-102, For The

Plastic Surgery News Latest Plastic Surgery News

LinkBack

Thread Tools

Display Modes

#1 (permalink)

01-31-2008, 03:25 PM

News Feeder4 News Feeder4 is offline

Senior Member

Join Date: Jun 2007

Posts: 6,897

My Photos: (0)

Tranzyme Pharma Receives IND Clearance For Its Oral Ghrelin Agonist, TZP-102, For The

Tranzyme Pharma announced that the US Food and Drug Administration (FDA) completed its review of the Company's Investigational New Drug (IND) application for TZP-102, Tranzyme's second drug candidate to reach clinical development. Tranzyme is a clinical stage company developing small molecule drugs for the treatment of gastrointestinal (GI) and metabolic diseases.
More...

« Sporting Events May Hurt Fans' Hearts | Spectators' Emotional Stress Linked To Heart Attacks »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts vB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On

All times are GMT. The time now is 06:58 PM.